RANDOX LABORATORIES, LTD. recalls Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for th…
- Recall date
- June 26, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2753-2020
- FDA classification
- Class II
- Brand / firm
- RANDOX LABORATORIES, LTD.
- Sold / distributed
- Worldwide distribution - US Nationwide distribution including in the states of Puerto Rico and WV.
Why it was recalled
Randox have confirmed imprecision of quality control and patient samples when using specific Randox Lipase R2 Substrate batches.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma.
Get recall alerts
Free email alert whenever RANDOX LABORATORIES, LTD. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RANDOX LABORATORIES, LTD.